Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Cell Death and Differentiation|April 18, 2003
EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cellsM Caraglia, P Tagliaferri, M Marra, et al.
Cell Death and Differentiation|September 1, 1999
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factorM Caraglia, A Abbruzzese, A Leardi, et al.
Prostate Cancer and Prostatic Diseases|January 19, 2005
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the diseaseG Di Lorenzo, S De Placido, R Autorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survivalG Fontanini, M De Laurentiis, S Vignati, et al.
International Journal of Oncology|December 22, 1999
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative GroupV Lorusso, G Palmieri, A R Bianco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunitsP Tagliaferri, G Tortora, R Guarrasi, et al.
British Journal of Cancer|May 11, 2006
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancerF Ciardiello, T Troiani, F Caputo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyC Gridelli, F Perrone, C Gallo, et al.
American Journal of Clinical Oncology|March 14, 1998
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effectsP Tagliaferri, C Barile, M Caraglia, et al.
Breast Cancer Research : BCR|November 1, 2000
BRCA1 and BRCA2 mutations in central and southern Italian patientsL Ottini, C D'Amico, C Noviello, et al.
Pageof 14